Inventor · disambiguated record
George V. Delucca
Also filed as: DELUCCA GEORGE · DELUCCA GEORGE V · DELUCCA GEORGE VINCENT
39 granted patents·4 pending applications·596 citations·filing 1996–2017
98Inventor score
Files withBRISTOL MYERS SQUIBB CO18BRISTOL MYERS SQUIBB PHARMA CO16BRSITOL MYERS SQUIBB PHARMA CO1DU PONT MERCK PHARMA1DU PONT PHARM CO1
Top patents by PatentIndex Score
43 records- 0197US9458156B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 4, 2016·25 cites·3 claims
- 0295US6525069B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 25, 2003·52 cites·28 claims
- 0394US8685969B2Carboline carboxamide compounds useful as kinase inhibitorsLIU CHUNJIAN·Filed 2011·Granted Apr 1, 2014·53 cites·15 claims
- 0494US8362065B2Carbazole carboxamide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·32 cites·20 claims
- 0593US8084620B2Carbazole carboxamide compounds useful as kinase inhibitorsLIU QINGJIE·Filed 2009·Granted Dec 27, 2011·60 cites·22 claims
- 0692US9273014B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·14 cites·11 claims
- 0792US6331541B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·57 cites·42 claims
- 0891US6759411B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 6, 2004·26 cites·45 claims
- 0991US6521592B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 18, 2003·28 cites·16 claims
- 1089US6605623B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Aug 12, 2003·36 cites·27 claims
- 1186US8999918B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2015·9 cites·19 claims
- 1285US9334290B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 10, 2016·5 cites·20 claims
- 1384US6974869B2Piperizinones as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Dec 13, 2005·13 cites·27 claims
- 1482US6441001B12-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 27, 2002·26 cites·59 claims
- 1581US9133139B2Fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·2 cites·10 claims
- 1679US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 1779US6444686B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRSITOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 3, 2002·58 cites·49 claims
- 1878US6331545B1Heterocycyclic piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·18 cites·53 claims
- 1977US7550486B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 23, 2009·2 cites·7 claims
- 2075US9725449B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·2 cites·17 claims
- 2175US6780857B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 24, 2004·6 cites·27 claims
- 2275US6313110B1Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitorDU PONT PHARM CO·Filed 2000·Granted Nov 6, 2001·6 cites·3 claims
- 2374US9751879B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 5, 2017·1 cites·13 claims
- 2472US6492400B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Dec 10, 2002·15 cites·23 claims
- 2571US7351720B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 1, 2008·4 cites·9 claims
- 2669US9714234B2Carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 2769US5763469ASubstituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Jun 9, 1998·14 cites·18 claims
- 2868US6897234B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted May 24, 2005·3 cites·26 claims
- 2968US6706735B22-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 16, 2004·3 cites·35 claims
- 3067US6919368B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jul 19, 2005·3 cites·15 claims
- 3167US6906066B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 14, 2005·3 cites·31 claims
- 3267US6875776B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 5, 2005·3 cites·22 claims
- 3366US6486180B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Nov 26, 2002·10 cites·32 claims
- 3465US10106559B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 3564US10112941B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 30, 2018·0 cites·3 claims
- 3663US7291744B2N-ureidoalkyl-amino compounds as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 6, 2007·2 cites·22 claims
- 3757US2016194338A1Substituted tetrahydrocarbazole and carbazoles carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3856US7514430B2Piperizinones as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Apr 7, 2009·0 cites·19 claims
- 3953US7312222B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Dec 25, 2007·0 cites·43 claims
- 4053US2005192291A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4151US9242941B2Alkyl, fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·0 cites·8 claims
- 4251US2005096325A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4346US2016318928A1Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George V. Delucca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →